CDC73 and pachyonychia congenita: However, targeted therapies are not available for PC and at present genetic testing for somatic CDC73 mutations using parathyroid tumor DNA may not be clinically useful for establishing the diagnosis or staging, especially as such tumors may contain multiple mutations.